Norwegian Translation and Validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR).

Tone Pr��sch-Bilden, Signe Nilssen Stafne, Silje Kristine Sveen Ulven, Susan Saga
Author Information
  1. Tone Pr��sch-Bilden: Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health, University Hospital of North Norway, Troms��, Norway.
  2. Signe Nilssen Stafne: Clinic of Rehabilitation, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
  3. Silje Kristine Sveen Ulven: Clinic of Surgery, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
  4. Susan Saga: Department of Public Health and Nursing, Faculty of Medicine and Health Sciences NTNU, Norwegian University of Science and Technology, Trondheim, Norway. susan.saga@ntnu.no. ORCID

Abstract

INTRODUCTION: The Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR) measures sexual function in women with pelvic floor dysfunctions (PFD). The aim of this study was to translate the PISQ-IR to Norwegian and to assess its psychometric properties.
METHODS: The instrument was translated and reviewed through cognitive interviews with women from the target group and multidisciplinary clinical experts to establish face/content validity and cultural equivalence. Thereafter, a cross-sectional study of women with PFD from two Norwegian University hospitals was conducted. Floor and ceiling effects and internal consistency were calculated for all subscales. Construct validity was assessed through exploratory factor analysis (EFA) and by testing 19 theoretically derived hypotheses.
RESULTS: Of 157 respondents, 111 (71%) women considered themselves sexually active (SA) and 46 (29%) non-sexually active (NSA). Item nonresponse rate varied from 4 to 36% in the subscales. For the NSA subscales, both floor and ceiling effect was detected. EFA mainly supported the original structure for both the SA and NSA subscales, although not completely consistent and with many cross-loadings. Unidimensional factors were assessed and confirmed the presence of one factor within all subscales for SA women and three for NSA women (except NSA-PR). Construct validity confirmed 16 of the 19 predefined hypotheses (84%). All subscales exhibited good internal consistency.
CONCLUSIONS: The Norwegian PISQ-IR demonstrated good face/content validity, internal consistency and construct validity, and can be used to assess sexual function among sexually active women with PFD. A small sample size of NSA women precludes drawing firm conclusions regarding structural validity for NSA subscales.

Keywords

References

  1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311���6. [DOI: 10.1001/jama.300.11.1311]
  2. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141���8. [DOI: 10.1097/AOG.0000000000000057]
  3. Stafne SN, Ulven SKS, Pr��sch-Bilden T, Saga S. Pelvic floor disorders and impact on sexual function: a cross-sectional study among non���sexually active and sexually active women. Sex Med. 2024;12(2):qfae024. [DOI: 10.1093/sexmed/qfae024]
  4. Saga S, Follestad T, Blekken LE. The impact of anal incontinence: psychosocial and sexual consequences and factors associated with QoL in a Norwegian outpatient population. Scand J Gastroenterol. 2024;59(10):1151���8. [DOI: 10.1080/00365521.2024.2392707]
  5. Verbeek M, Hayward L. Pelvic floor dysfunction and its effect on quality of sexual life. Sex Med Rev. 2019;7(4):559���64. [DOI: 10.1016/j.sxmr.2019.05.007]
  6. Srikrishna S, Cardozo L. Quality of life and patient reported outcomes. Glob Libr Women���s Med. 2014. https://doi.org/10.3843/GLOWM.10477 .
  7. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D���Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191���208. [DOI: 10.1080/009262300278597]
  8. Rogers RG, Rockwood TH, Constantine ML, Thakar R, Kammerer-Doak DN, Pauls RN, Parekh M, Ridgeway B, Jha S, Pitkin J, Reid F, Sutherland SE, Domoney C, Sand P, Davila GW, Pons EE. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2013;24:1091���103. [DOI: 10.1007/s00192-012-2020-8]
  9. Gray TG, Vickers H, Krishnaswamy P, Jha S. A systematic review of English language patient-reported outcome measures for use in urogynaecology and female pelvic medicine. Int Urogynecol J. 2021;32(8):2033���92. [DOI: 10.1007/s00192-021-04810-1]
  10. Mestre M, Lleberia J, Pubill J, Espu��a-Pons M. Spanish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA-Revised (PISQ-IR): Transcultural validation. Int Urogynecol J. 2017;28(12):1865���73. [DOI: 10.1007/s00192-017-3312-9]
  11. Wang H, Lau HH, Hung MJ, Huang WC, Zheng YW, Su TH. Validation of a Mandarin Chinese version of the pelvic organ prolapse/urinary incontinence sexual questionnaire IUGA-revised (PISQ-IR). Int Urogynecol J. 2015;26(11):1695���700. [DOI: 10.1007/s00192-015-2744-3]
  12. El-Azab AS, Ghoniem GM, Leu SY, Nguyen DV. Arabic validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2015;26:1229���37. [DOI: 10.1007/s00192-015-2678-9]
  13. Farkas B, Tiringer I, Farkas N, Kenyeres B, Nemeth Z. Hungarian language validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2016;27:1831���6. [DOI: 10.1007/s00192-016-3047-z]
  14. Trutnovsky G, Nagele E, Ulrich D, Aigm��ller T, D��rfler D, Geiss I, Reinstadler E, Angleitner-Flotzinger J, Ries JJ, Bjelic-Radisic V. German translation and validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2016;27(8):1235���44. [DOI: 10.1007/s00192-016-2969-9]
  15. Fatton B, Hermieu JF, Lucot JP, Debodinance P, Cour F, Alonso S, de Tayrac R. French validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2021;32(12):3183���98. [DOI: 10.1007/s00192-020-04625-6]
  16. van Dongen H, van der Vaart H, Kluivers KB, Elzevier H, Roovers JP, Milani AL. Dutch translation and validation of the pelvic organ prolapse/incontinence sexual questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2019;30(1):107���14. [DOI: 10.1007/s00192-018-3718-z]
  17. Mokkink LB, Terwee CB, Patrick D, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HCW. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539���49. [DOI: 10.1007/s11136-010-9606-8]
  18. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011. [DOI: 10.1017/CBO9780511996214]
  19. Rockwood TH, Constantine ML, Adegoke O, Rogers RG, McDermott E, Davila GW, Domoney C, Jha S, Kammerer-Doak D, Lukacz ES, Parekh M, Pauls R, Pitkin J, Reid F, Ridgeway B, Thakar R, Sand PK, Sutherland SE, Espuna-Pons M. The PISQ-IR: considerations in scale scoring and development. Int Urogynecol J. 2013;24(7):1105���22. [DOI: 10.1007/s00192-012-2037-z]
  20. Constantine ML, Pauls RN, Rogers RR, Rockwood TH. Validation of a single summary score for the Prolapse/Incontinence Sexual Questionnaire���IUGA revised (PISQ-IR). Int Urogynecol J. 2017;28:1901���7. [DOI: 10.1007/s00192-017-3373-9]
  21. Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44(1):77���80. [DOI: 10.1136/gut.44.1.77]
  22. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322���30. [DOI: 10.1002/nau.20041]
  23. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103���13. [DOI: 10.1016/j.ajog.2004.12.025]
  24. Teig CJ, Grotle M, Bond MJ, Prinsen CAC, Engh MAE, Cvancarova MS, Kj��llesdal M, Martini A. Norwegian translation and validation of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7). Int Urogynecol J. 2017;28(7):1005���17. [DOI: 10.1007/s00192-016-3209-z]
  25. Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009;28(5):411���5. [DOI: 10.1002/nau.20674]
  26. Pallant J. SPSS survival manual: a step by step guide to data analysis using SPSS program. 6th ed. London: McGraw-Hill; 2016.
  27. Thin NN, Taylor SJ, Bremner SA, Emmanuel AV, Hounsome N, Williams NS, Knowles CH, Neuromodulation Trial Study Group. Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. Br J Surg. 2015;102(4):349���58. [DOI: 10.1002/bjs.9695]
  28. Karjalainen PK, Mattsson NK, Jalkanen JT, Nieminen K, Tolppanen AM. Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery. Int Urogynecol J. 2021;32(12):3169���76. [DOI: 10.1007/s00192-020-04513-z]
  29. Cichowski SB, Komesu YM, Dunivan GC, Rogers RG. The association between fecal incontinence and sexual activity and function in women attending a tertiary referral center. Int Urogynecol J. 2013;24(9):1489���94. [DOI: 10.1007/s00192-013-2044-8]
  30. Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 3rd ed. Upper Saddle River: Pearson; 2009.

Grants

  1. 46083300/The Joint Research Committee between St Olavs Hospital and the Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology

Word Cloud

Created with Highcharts 10.0.0womensubscalesvalidityNSAPISQ-IRPelvicNorwegianSexualfunctionfloorPFDinternalconsistencyactiveSAOrganProlapse/IncontinenceQuestionnaire-IUGAsexualstudyassessface/contentceilingConstructassessedfactorEFA19hypothesessexuallyconfirmedgoodINTRODUCTION:revisedmeasurespelvicdysfunctionsaimtranslatepsychometricpropertiesMETHODS:instrumenttranslatedreviewedcognitiveinterviewstargetgroupmultidisciplinaryclinicalexpertsestablishculturalequivalenceThereaftercross-sectionaltwoUniversityhospitalsconductedFlooreffectscalculatedexploratoryanalysistestingtheoreticallyderivedRESULTS:157respondents11171%considered4629%non-sexuallyItemnonresponseratevaried436%effectdetectedmainlysupportedoriginalstructurealthoughcompletelyconsistentmanycross-loadingsUnidimensionalfactorspresenceonewithinthreeexceptNSA-PR16predefined84%exhibitedCONCLUSIONS:demonstratedconstructcanusedamongsmallsamplesizeprecludesdrawingfirmconclusionsregardingstructuralTranslationValidationRevisedIncontinencedysfunctionorganprolapsePsychometricvalidation

Similar Articles

Cited By

No available data.